DAWN RUSSI: Open Payments
NPI 1831549765 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 46 payments from 19 companies in 2025. Trend: 2023 $1,422 · 2024 $908 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 6 | $128 |
| Ascendis Pharma Endocrinology Inc | 5 | $114 |
| Insulet Corporation | 4 | $109 |
| Lilly USA, LLC | 5 | $107 |
| Amgen Inc. | 3 | $55 |
| Almatica Pharma LLC | 3 | $52 |
| United Therapeutics Corporation | 2 | $51 |
| Tandem Diabetes Care, Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
Products named: GVOKE HYPOPEN, Yorvipath, Omnipod, MOUNJARO, EVENITY, TERIPARATIDE, Tyvaso, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across FL — which companies pay providers there.
